WHO:World Health Organization. Department of Measurement and Health Information. 2004. [http://www.who.int/healthinfo/statistics/bodgbddeathdalyestimates.xls]
Google Scholar
Raja NS, Janjua NK: Epidemiology of hepatitis C virus infection in Pakistan. J Microbiol Immunol Infect. J Microbiol Immunol Infect 2008, 41: 4-8.
PubMed
Google Scholar
Alter MJ, Mast EE, Moyer LA, Margolis HS: Hepatitis C. Infect Dis Clin North Am 1998, 12: 13-26. 10.1016/S0891-5520(05)70405-0
Article
CAS
PubMed
Google Scholar
Lindenbach BD, Rice CM: Unravelling hepatitis C virus replication from genome to function. Nature 2005, 436: 933-938. 10.1038/nature04077
Article
CAS
PubMed
Google Scholar
Reed KE, Rice CM: Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Curr Top Microbiol Immunol 2000, 242: 55-84.
CAS
PubMed
Google Scholar
Grakoui A, Wychowski C, Lin C, Feinstone SM, Rice CM: Expression and identification of hepatitis C virus polyprotein cleavage products. J Virol 1993, 67: 1385-1395.
PubMed Central
CAS
PubMed
Google Scholar
Lin C, Lindenbach BD, Pragai BM, McCourt DW, Rice CM: Processing in the hepatitis C virus E2-NS2 region: identification of p7 and two distinct E2-specific products with different C termini. J Virol 1994, 68: 5063-5073.
PubMed Central
CAS
PubMed
Google Scholar
Selby MJ, Choo QL, Berger K, Kuo G, Glazer E, Eckart M, Lee C, Chien D, Kuo C, Houghton M: Expression, identification and subcellular localization of the proteins encoded by the hepatitis C viral genome. J Gen Virol 1993,74(Pt 6):1103-1113.
Article
CAS
PubMed
Google Scholar
Bartenschlager R, Ahlborn-Laake L, Mous J, Jacobsen H: Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctions. J Virol 1993, 67: 3835-3844.
PubMed Central
CAS
PubMed
Google Scholar
De Francesco R, Neddermann P, Tomei L, Steinkuhler C, Gallinari P, Folgori A: Biochemical and immunologic properties of the nonstructural proteins of the hepatitis C virus: implications for development of antiviral agents and vaccines. Semin Liver Dis 2000, 20: 69-83. 10.1055/s-2000-9504
Article
CAS
PubMed
Google Scholar
Hijikata M, Mizushima H, Akagi T, Mori S, Kakiuchi N, Kato N, Tanaka T, Kimura K, Shimotohno K: Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus. J Virol 1993, 67: 4665-4675.
PubMed Central
CAS
PubMed
Google Scholar
Lin C, Pragai BM, Grakoui A, Xu J, Rice CM: Hepatitis C virus NS3 serine proteinase: trans-cleavage requirements and processing kinetics. J Virol 1994, 68: 8147-8157.
PubMed Central
CAS
PubMed
Google Scholar
Lin C, Rice CM: The hepatitis C virus NS3 serine proteinase and NS4A cofactor: establishment of a cell-free trans-processing assay. Proc Natl Acad Sci USA 1995, 92: 7622-7626. 10.1073/pnas.92.17.7622
Article
PubMed Central
CAS
PubMed
Google Scholar
Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium J Viral Hepat 1999, 6: 35-47.
Hadziyannis SJ, Papatheodoridis GV: Peginterferon-alpha2a (40 kDa) for chronic hepatitis C. Expert Opin Pharmacother 2003, 4: 541-551.
CAS
PubMed
Google Scholar
Conjeevaram HS, Fried MW, Jeffers LJ, Terrault NA, Wiley-Lucas TE, Afdhal N, Brown RS, Belle SH, Hoofnagle JH, Kleiner DE, Howell CD: Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1. Gastroenterology 2006, 131: 470-477. 10.1053/j.gastro.2006.06.008
Article
CAS
PubMed
Google Scholar
Di Bisceglie AM, Conjeevaram HS, Fried MW, Sallie R, Park Y, Yurdaydin C, Swain M, Kleiner DE, Mahaney K, Hoofnagle JH: Ribavirin as therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1995, 123: 897-903.
Article
CAS
PubMed
Google Scholar
Arbuthnot P, Longshaw V, Naidoo T, Weinberg MS: Opportunities for treating chronic hepatitis B and C virus infection using RNA interference. J Viral Hepat 2007, 14: 447-459. 10.1111/j.1365-2893.2006.00818.x
Article
CAS
PubMed
Google Scholar
Patrick L: Hepatitis C: epidemiology and review of complementary/alternative medicine treatments. Altern Med Rev 1999, 4: 220-238.
CAS
PubMed
Google Scholar
Hussein G, Miyashiro H, Nakamura N, Hattori M, Kakiuchi N, Shimotohno K: Inhibitory effects of sudanese medicinal plant extracts on hepatitis C virus (HCV) protease. Phytother Res 2000, 14: 510-516. 10.1002/1099-1573(200011)14:7<510::AID-PTR646>3.0.CO;2-B
Article
CAS
PubMed
Google Scholar
Oka H, Yamamoto S, Kuroki T, Harihara S, Marumo T, Kim SR, Monna T, Kobayashi K, Tango T: Prospective study of chemoprevention of hepatocellular carcinoma with Sho-saiko-to (TJ-9). Cancer 1995, 76: 743-749. 10.1002/1097-0142(19950901)76:5<743::AID-CNCR2820760506>3.0.CO;2-V
Article
CAS
PubMed
Google Scholar
Tusenius KJ, Spoek JM, Kramers CW: Iscador Qu for chronic hepatitis C: an exploratory study. Complement Ther Med 2001, 9: 12-16. 10.1054/ctim.2000.0408
Article
CAS
PubMed
Google Scholar
Grinde B, Hetland G, Johnson E: Effects on gene expression and viral load of a medicinal extract from Agaricus blazei in patients with chronic hepatitis C infection. Int Immunopharmacol 2006, 6: 1311-1314. 10.1016/j.intimp.2006.04.005
Article
CAS
PubMed
Google Scholar
Watashi K, Shimotohno K: Chemical genetics approach to hepatitis C virus replication: cyclophilin as a target for anti-hepatitis C virus strategy. Rev Med Virol 2007, 17: 245-252. 10.1002/rmv.534
Article
CAS
PubMed
Google Scholar
Lee HY, Yum JH, Rho YK, Oh SJ, Choi HS, Chang HB, Choi DH, Leem MJ, Choi EJ, Ryu JM, Hwang SB: Inhibition of HCV replicon cell growth by 2-arylbenzofuran derivatives isolated from Mori Cortex Radicis. Planta Med 2007, 73: 1481-1485. 10.1055/s-2007-990249
Article
CAS
PubMed
Google Scholar
Dai J, Carte BK, Sidebottom PJ, Sek Yew AL, Ng S, Huang Y, Butler MS: Circumdatin G, a new alkaloid from the fungus Aspergillus ochraceus. J Nat Prod 2001, 64: 125-126. 10.1021/np000381u
Article
CAS
PubMed
Google Scholar
Zekri AR, Bahnassy AA, El-Din HM, Salama HM: Consensus siRNA for inhibition of HCV genotype-4 replication. Virol J 2009, 6: 13. 10.1186/1743-422X-6-13
Article
PubMed Central
PubMed
Google Scholar
el-Awady MK, Tabll AA, el-Abd YS, Bahgat MM, Shoeb HA, Youssef SS, Bader el-Din NG, Redwan el RM, el-Demellawy M, Omran MH, et al.: HepG2 cells support viral replication and gene expression of hepatitis C virus genotype 4 in vitro. World J Gastroenterol 2006, 12: 4836-4842.
PubMed Central
CAS
PubMed
Google Scholar
Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65: 55-63. 10.1016/0022-1759(83)90303-4
Article
CAS
PubMed
Google Scholar
Molina S, Castet V, Pichard-Garcia L, Wychowski C, Meurs E, Pascussi JM, Sureau C, Fabre JM, Sacunha A, Larrey D, et al.: Serum-derived hepatitis C virus infection of primary human hepatocytes is tetraspanin CD81 dependent. J Virol 2008, 82: 569-574. 10.1128/JVI.01443-07
Article
PubMed Central
CAS
PubMed
Google Scholar
Kubmarawa D, Ajoku GA, Enwerem NM, Okorie DA: Preliminary phytochemical and antimicrobial screening of 50 medicinal plants from Nigeria. Afr J Biotechnol 2007, 6: 1690-1696.
CAS
Google Scholar
Pai MB, Prashant GM, Murlikrishna KS, Shivakumar KM, Chandu GN: Antifungal efficacy of Punica granatum, Acacia nilotica, Cuminum cyminum and Foeniculum vulgare on Candida albicans: an in vitro study. Indian J Dent Res 21: 334-336.
Meena PD, Kaushik P, Shukla S, Soni AK, Kumar M, Kumar A: Anticancer and antimutagenic properties of Acacia nilotica (Linn.) on 7,12-dimethylbenz(a)anthracene-induced skin papillomagenesis in Swiss albino mice. Asian Pac J Cancer Prev 2006, 7: 627-632.
PubMed
Google Scholar
Agrawal R, Mishra B, Tyagi E, Nath C, Shukla R: Effect of curcumin on brain insulin receptors and memory functions in STZ (ICV) induced dementia model of rat. Pharmacol Res 2010, 61: 247-252. 10.1016/j.phrs.2009.12.008
Article
CAS
PubMed
Google Scholar
Kitazato K, Wang Y, Kobayashi N: Viral infectious disease and natural products with antiviral activity. Drug Discov Ther 2007., 1:
Google Scholar
Ashfaq UA, Javed T, Rehman S, Nawaz Z, Riazuddin S: Inhibition of HCV 3a core gene through Silymarin and its fractions. Virology Journal 2011, 8: 153. 10.1186/1743-422X-8-153
Article
PubMed Central
CAS
PubMed
Google Scholar